Targeting Care. Tailoring Nonsurgical Management According to Clinical Presentation.

Rheumatic Disease Clinics of North America

Volumn 39, Issue 1, 2013, Pages 213-233

  Eyles, Jillian ^a   Lucas, Barbara R ^a   Hunter, David J ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Clinical predictors; Osteoarthritis; Treatment response

Indexed keywords

BUPIVACAINE; CELECOXIB; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; ETORICOXIB; GLUCOSAMINE SULFATE; HYALURONIC ACID; KETOPROFEN; LIDOCAINE; METHYLPREDNISOLONE ACETATE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM; PLACEBO; ROFECOXIB;

ANALGESIA; ANTIINFLAMMATORY ACTIVITY; ANXIETY DISORDER; BODY MASS; BODY WEIGHT; BRACE; CALCINOSIS; CHRONIC PAIN; CONSERVATIVE TREATMENT; DEPRESSION; DIET THERAPY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG CHOICE; HIP OSTEOARTHRITIS; HIP PAIN; HOME CARE; HUMAN; INFLAMMATION; JOINT CAVITY; JOINT EFFUSION; JOINT RADIOGRAPHY; JOINT SWELLING; KINESIOTHERAPY; KNEE OSTEOARTHRITIS; KNEE PAIN; LIMB WEAKNESS; MANIPULATIVE MEDICINE; MOOD; MUSCLE STRENGTH; MUSCLE TRAINING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITIONAL COUNSELING; OBESITY; OSTEOARTHRITIS; OSTEOPHYTE; PATHOPHYSIOLOGY; PATIENT EDUCATION; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUADRICEPS FEMORIS MUSCLE; QUALITY OF LIFE; RATING SCALE; REHABILITATION CARE; REVIEW; RHEUMATOID ARTHRITIS; SYNOVITIS; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VALGUS KNEE; VALGUS TIBIOFEMORAL JOINT ALIGNMENT; VARUS KNEE; VARUS TIBIOFEMORAL JOINT ALIGNMENT; WEIGHT BEARING; WEIGHT REDUCTION;

AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; BONE MALALIGNMENT; DISEASE PROGRESSION; EXERCISE THERAPY; FEMALE; HUMANS; JOINTS; MALE; MIDDLE AGED; MUSCLE STRENGTH; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; PATIENT-CENTERED CARE; PREDICTIVE VALUE OF TESTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84872335878     PISSN: 0889857X     EISSN: 15583163     Source Type: Journal    
DOI: 10.1016/j.rdc.2012.11.001     Document Type: Review

References (68)

1. World Health Organization. Chronic diseases and health promotion: chronic rheumatic conditions. Available at: Accessed September 17, 2012. http://www.who.int/chp/topics/rheumatic/en/.
2. Murray C., Lopez A. The global burden of disease. A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 1996, Harvard School of Public Health on behalf of the World Health Organization and The World Bank, Cambridge (MA).
3. Centers for Disease Control and Prevention (CDC) National and state medical expenditures and lost earnings attributable to arthritis and other rheumatic conditions-United States. MMWR Morb Mortal Wkly Rep 2007, 56:4-7.
4. Zhang W., Moskowitz R., Nuki G., et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008, 16(12):137-162.
5. Zhang W., Doherty M., Arden N.K., et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2005, 64:669-681.
6. Pendleton A., Arden N., Dougados M., et al. EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2000, 59:936-944.
7. Royal Australian College of General Practitioners Guideline for the non-surgical management of hip and knee osteoarthritis 2009, Royal Australian College of General Practitioners, South Melbourne (Australia).
8. Zhang W., Nuki G., Moskowitz R.W., et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 2010, 18(4):476-499.
9. NICE and Royal College of Physicians Guidelines on Osteoarthritis. Osteoarthritis-national clinical guideline for care and management in adults. United Kingdom 2008. Available at: Accessed September 18, 2012. http://guidance.nice.org.uk/CG59.
10. Hochberg M.C., Altman R.D., April K.T., et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 2012, 64(4):465-474.
11. Misso M., Pitt V., Jones K., et al. Quality and consistency of clinical practice guidelines for diagnosis and management of osteoarthritis of the hip and knee: a descriptive overview of published guidelines. Med J Aust 2008, 189(7):394-399.
12. Janssen I., Mark A.E. Separate and combined influence of body mass index and waist circumference on arthritis and knee osteoarthritis. Int J Obes 2006, 30(8):1223-1228.
13. Chapple C.M., Nicholson H., Baxter G.D., et al. Patient characteristics that predict progression of knee osteoarthritis: a systematic review of prognostic studies. Arthritis Care Res (Hoboken) 2011, 63(8):1115-1125.
14. Heliövaara M., Mäkelä M., Impivaara O., et al. Association of overweight, trauma and workload with coxarthrosis: a health survey of 7,217 persons. Acta Orthop Scand 1993, 64(5):513-518.
15. Karlson E., Mandl L., Aweh G., et al. Total hip replacement due to osteoarthritis the importance of age, obesity, and other modifiable risk factors. Am J Med 2003, 114(2):93-98.
16. Brand C., Hunter D.J., Hinman R.S., et al. Improving are for people with OA of the hip and knee: how has national policy for OA been translated into service models in Australia. Int J Rheum Dis 2011, 14:181-190.
17. Wolf S., Foley S., Budiman-Mak E., et al. Predictors of weight loss in overweight veterans with knee osteoarthritis who participated in a clinical trial. J Rehabil Res Dev 2010, 47(3):171-181.
18. Snijders G.F., den Broeder A.A., van Riel P.L., et al. Evidence-based tailored conservative treatment of knee and hip osteoarthritis: between knowing and doing. Scand J Rheumatol 2011, 40(3):225-231.
19. Snijders G.F. Treatment outcomes of a Numeric Rating Scale (NRS)-guided pharmacological pain management strategy in symptomatic knee and hip osteoarthritis in daily clinical practice. Clin Exp Rheumatol 2012, 30(2):164-170.
20. Bingham C.O., Smugar S.S., Wang H., et al. Predictors of response to cyclo-oxygenase-2 inhibitors in osteoarthritis: pooled results from two identical trials comparing etoricoxib, celecoxib, and placebo. Pain Med 2011, 12(3):352-361.
21. Detora L., Krupta D., Bolognese J., et al. Rofecoxib shows consistent efficacy in OA clinical trials, regardless of specific patient demographic and disease factors. J Rheumatol 2001, 28(11):2494-2503.
22. Robinson P., Keenan A.M., Conaghan P.G. Clinical effectiveness and dose response of image-guided intra-articular corticosteroid injection for hip osteoarthritis. Rheumatology 2007, 46(2):285-291.
23. Kemper F., Gebhardt U., Meng T., et al. Tolerability and short-term effectiveness of Hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice. Curr Med Res Opin 2005, 21(8):1261-1269.
24. Conrozier T., Mathieu P., Schott A., et al. Factors predicting long-term efficacy of Hylan GF-20 viscosupplementation in knee osteoarthritis. Joint Bone Spine 2003, 70:128-133.
25. Anandacoomarasamy A., Bagga H., Ding C., et al. Predictors of clinical response to intraarticular Hylan injections-a prospective study using synovial fluid measures, clinical outcomes and magnetic resonance imaging. J Rheumatol 2008, 35(4):685-690.
26. Goorman S., Watanabe T., Miller E., et al. Functional outcome in knee osteoarthritis after treatment with Hylan G-F 20: a prospective study. Arch Phys Med Rehabil 2000, 81:479-483.
27. Migliore A., Tormenta S., Massafra U., et al. Intra-articular administration of Hylan G-F 20 in patients with symptomatic hip osteoarthritis: tolerability and effectiveness in a large cohort study in clinical practice. Curr Med Res Opin 2008, 24(5):1309-1316.
28. Bennett A.N., Crossley K.M., Brukner P.D., et al. Predictors of symptomatic response to glucosamine in knee osteoarthritis: an exploratory study. Br J Sports Med 2007, 41(7):415-419.
29. Roseman T., Backenstrass M., Rosemann A., et al. Predictors of depression in a sample of 1021 primary care patients with osteoarthritis. Arthritis Rheum 2007, 57(3):415-422.
30. Wise B.L., Niu J., Zhang Y., et al. Psychological factors and their relation to osteoarthritis pain. Osteoarthritis Cartilage 2010, 18:883-887.
31. Lin E.H., Katon W., Von Korff M., et al. Effect of improving depression care on pain and functional outcomes among older adults with arthritis: a randomized controlled trial. JAMA 2003, 290(18):2428-2429.
32. Weigl M., Angst F., Aeschlimann A., et al. Predictors for response to rehabilitation in patients with hip or knee osteoarthritis: a comparison of logistic regression models with three different definitions of responder. Osteoarthritis Cartilage 2006, 14(7):641-651.
33. Jones A., Doherty M. Intra-articular corticosteroids are effective in osteoarthritis but there are no clinical predictors of response. Ann Rheum Dis 1996, 55:829-832.
34. Walker J., Sheather-Reid R., Carmody J., et al. Nonsteroidal antiinflammatory drugs in rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1997, 40(11):1944-1954.
35. Palmieri-Smith R.M., Thomas A.C., Karvonen-Gutierrez C., et al. Isometric quadriceps strength in women with mild, moderate, and severe knee osteoarthritis. Am J Phys Med Rehabil 2010, 89(7):541-548.
36. Segal N.A., Torner J.C., Felson D., et al. Effect of thigh strength on incident radiographic and symptomatic knee osteoarthritis in a longitudinal cohort. Arthritis Rheum 2009, 61(9):1210-1217.
37. Amin S., Baker K., Niu J., et al. Quadriceps strength and the risk of cartilage loss and symptom progression in knee osteoarthritis. Arthritis Rheum 2009, 60(1):189-198.
38. Roos E.M., Herzog W., Block J.A., et al. Muscle weakness, afferent sensory dysfunction and exercise in knee osteoarthritis. Nat Rev Rheumatol 2012, 7(1):57-63.
39. Suetta C., Aagaard P., Magnusson S., et al. Muscle size, neuromuscular activation, and rapid force characteristics in elderly men and women: effects of unilateral long-term disuse due to hip osteoarthritis. J Appl Physiol 2007, 102:942-948.
40. Fransen M., McConnell S. Land-based exercise for osteoarthritis of the knee: a metaanalysis of randomized controlled trials. J Rheumatol 2009, 36(6):1109-1117.
41. Fransen M., McConnell S., Hernandez-Molina G., et al. Does land-based exercise reduce pain and disability associated with hip osteoarthritis? A meta-analysis of randomized controlled trials. Osteoarthritis Cartilage 2010, 18(5):613-620.
42. Wright A., Cook C., Flynn T., et al. Predictors of response to physical therapy intervention in patients with primary hip osteoarthritis. Phys Ther 2011, 91(4):510-524.
43. Sattler M., Dannhauer T., Hudelmaier M., et al. Side differences of thigh muscle cross-sectional areas and maximal isometric muscle force in bilateral knees with the same radiographic disease stage, but unilateral frequent pain-data from the osteoarthritis initiative. Osteoarthritis Cartilage 2012, 20(6):532-540.
44. Pietrosimone B.G., Hertel J., Ingersoll C.D., et al. Voluntary quadriceps activation deficits in patients with tibiofemoral osteoarthritis: a meta-analysis. PM R 2011, 3(2):153-162. [quiz: 62].
45. Scopaz K.A., Piva S.R., Gil A.B., et al. Effect of baseline quadriceps activation on changes in quadriceps strength after exercise therapy in subjects with knee osteoarthritis. Arthritis Rheum 2009, 61(7):951-957.
46. Gudbergsen H., Boesen M., Lohmander L.S., et al. Weight loss is effective for symptomatic relief in obese subjects with knee osteoarthritis independently of joint damage severity assessed by high-field MRI and radiography. Osteoarthritis Cartilage 2012, 20(6):495-502.
47. Hunter D.J., Niu J., Felson D.T., et al. Knee alignment does not predict incident osteoarthritis: the Framingham osteoarthritis study. Arthritis Rheum 2007, 56(4):1212-1218.
48. Brouwer G., vanTol A., Bergink A., et al. Association between valgus and varus alignment and the development and progression of radiographic osteoarthritis of the knee. Arthritis Rheum 2007, 56(4):1204-1211.
49. Hinman R.S., Payne C., Metcalf B.R., et al. Lateral wedges in knee osteoarthritis: what are their immediate clinical and biomechanical effects and can these predict a three-month clinical outcome?. Arthritis Rheum 2008, 59(3):408-415.
50. Cooke T., Sled E., Scudamore R. Frontal plane knee alignment: a call for standardised measurement. J Rheumatol 2007, 34:1796-1801.
51. Andriacchi T. Dynamics of knee malalignment. Orthop Clin North Am 1994, 25:395-403.
52. Bennell K.L., Hunt M.A., Wrigley T.V., et al. Hip strengthening reduces symptoms but not knee load in people with medial knee osteoarthritis and varus malalignment: a randomised controlled trial. Osteoarthritis Cartilage 2010, 18(5):621-628.
53. Foroughi N., Smith R.M., Lange A.K., et al. Progressive resistance training and dynamic alignment in osteoarthritis: a single-blind randomised controlled trial. Clin Biomech (Bristol, Avon) 2011, 26(1):71-77.
54. Sharma L., Dunlop D., Cahue S., et al. Quadriceps strength and osteoarthritis progression in malaligned and lax knees. Ann Intern Med 2003, 138:613-619.
55. Sharma L., Song J., Felson D., et al. The role of knee alignment in disease progression and functional decline in knee osteoarthritis. JAMA 2001, 286:792.
56. Lim B.W., Hinman R.S., Wrigley T.V., et al. Varus malalignment and its association with impairments and functional limitations in medial knee osteoarthritis. Arthritis Rheum 2008, 59(7):935-942.
57. Lim B.W., Hinman R.S., Wrigley T.V., et al. Does knee malalignment mediate the effects of quadriceps strengthening on knee adduction moment, pain and function in medial knee osteoarthritis? A randomized controlled trial. Arthritis Rheum 2008, 59(7):943-951.
58. Guermazi A., Burstein D., Conaghan P., et al. Imaging in osteoarthritis. Rheum Dis Clin North Am 2008, 34(3):645-687.
59. Conaghan P.G., Hunter D.J., Maillefert J.F., et al. Summary and recommendations of the OARSI FDA osteoarthritis Assessment of Structural Change Working Group. Osteoarthritis Cartilage 2011, 19(5):606-610.
60. Gudbergsen H., Boesen M., Christensen R., et al. Radiographs and low field MRI (0.2T) as predictors of efficacy in a weight loss trial in obese women with knee osteoarthritis. BMC Musculoskelet Disord 2011, 12:56.
61. Case J.P., Baliunas A.J., Block J.A. Lack of efficacy of acetaminophen in treating symptomatic knee osteoarthritis: a randomized, double-blind, placebo-controlled comparison trial with diclofenac sodium. Arch Intern Med 2003, 163(2):169-178.
62. Deshmukh A.J., Panagopoulos G., Alizadeh A., et al. Intra-articular hip injection: does pain relief correlate with radiographic severity of osteoarthritis?. Skeletal Radiol 2011, 40(11):1449-1454.
63. Plant M., Borg A., Dziedzic K., et al. Radiographic patterns and response to corticosteroid hip injection. Ann Rheum Dis 1997, 56:476-480.
64. Atchia I., Kane D., Reed M., et al. Efficacy of a single ultrasound-guided injection for the treatment of hip osteoarthritis. Ann Rheum Dis 2011, 70:110-116.
65. Loeser R.F., Goldring S.R., Scanzello C.R., et al. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum 2012, 64(6):1697-1707.
66. Chao J., Wu C., Sun B., et al. Inflammatory characteristics on ultrasound predict poorer longterm response to intraarticular corticosteroid injections in knee osteoarthritis. J Rheumatol 2010, 37(3):650-655.
67. Pendleton A., Millar A., O'Kane D., et al. Can sonography be used to predict the response to intra-articular corticosteroid injection in primary osteoarthritis of the knee?. Scand J Rheumatol 2008, 37(5):395-397.
68. Babyak M. What you see may not be what you get: a brief, non-technical introduction to overfitting in regression-type models. Psychosom Med 2004, 66:411-421.